22
Views
15
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Effects of raloxifene therapy on the anticoagulant system in postmenopausal women

, , , , &
Pages 140-145 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Derun Taner Ertugrul, Alptekin Gürsoy, Muammer Yücel, Mustafa Sahin, Asli Dogruk Unal, Baris Pamuk, Zehra Berberoglu, Semra Aytürk, Neslihan Bascil Tutuncu & Nilgun Guvener Demirag. (2006) Effects of raloxifene on platelet functions in patients with postmenopausal osteoporosis. Platelets 17:6, pages 351-353.
Read now

Articles from other publishers (14)

Denys Alva-Chavarría, Maribel Soto-Núñez, Edgar Flores-Soto & Ruth Jaimez. (2023) Hemostatic Effects of Raloxifene in Ovariectomized Rats. Life 13:7, pages 1612.
Crossref
Michael E. Plazak, Stephen J. Hankinson, Erik N. Sorensen, Brent N. Reed, Bharath Ravichandran & Van-Khue Ton. (2020) Novel Use of Tamoxifen to Reduce Recurrent Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices. Journal of Cardiovascular Translational Research 14:3, pages 484-491.
Crossref
D. L. Kendler, S. Palacios, D. A. Cox, J. Stock, J. Alam, S. A. Dowsett & J. Zanchetta. (2011) Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis. Osteoporosis International 23:3, pages 1091-1101.
Crossref
Steven R. Goldstein, Claire S. Duvernoy, Joaquim Calaf, Jonathan D. Adachi, John L. Mershon, Sherie A. Dowsett, Donato Agnusdei & Cynthia A. Stuenkel. (2009) Raloxifene use in clinical practice. Menopause 16:2, pages 413-421.
Crossref
Lori MoscaDeborah GradyElizabeth Barrett-ConnorPeter CollinsNanette WengerBeth L. AbramsonAnnlia Paganini-HillMary Jane GeigerSherie A. DowsettMessan Amewou-AtissoMarcel Kornitzer. (2009) Effect of Raloxifene on Stroke and Venous Thromboembolism According to Subgroups in Postmenopausal Women at Increased Risk of Coronary Heart Disease. Stroke 40:1, pages 147-155.
Crossref
Anette Løken Eilertsen, Leiv Sandvik, Marie Christine Mowinckel, Trine Opstad Andersen, Erik Qvigstad & Per Morten Sandset. (2007) Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. Thrombosis Research 120:3, pages 371-379.
Crossref
Tatjana El??ne Vogelvang, Marius Jan van der Mooren, Velja Mijatovic & Peter Kenemans. (2006) Emerging Selective Estrogen Receptor Modulators. Drugs 66:2, pages 191-221.
Crossref
George Dantas Azevedo, Rendrik França Franco, Márcia Sueli Baggio, Técia Maria de Oliveira Maranhão & Marcos Felipe Silva de Sá. (2005) Procoagulant state after raloxifene therapy in postmenopausal women. Fertility and Sterility 84:6, pages 1680-1684.
Crossref
Mehmet Ozeren, S. Caner Karahan, Mustafa Ozgur, Selcuk Eminagaoglu, Mesut Unsal, Sukrucan Baytan & Hasan Bozkaya. (2005) The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1. Acta Obstetricia et Gynecologica Scandinavica 84:10, pages 987-991.
Crossref
Tatjana E. Vogelvang, Velja Mijatovic, Peter Kenemans, Jef J. Emeis, Johannes A. Heijst & Marius J. van der Mooren. (2005) The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: A randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women. American Journal of Obstetrics and Gynecology 193:4, pages 1384-1394.
Crossref
Claire S Duvernoy, Pandurang M Kulkarni, Sherie A Dowsett & Cheryl A Keech. (2005) Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics, and effect of raloxifene. Menopause 12:4, pages 444-452.
Crossref
Ann Cranney & Jonathan D Adachi. (2005) Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis. Drug Safety 28:8, pages 721-730.
Crossref
F. Cosman, M. Baz-Hecht, M. Cushman, M.D. Vardy, J.D. Cruz, J.W. Nieves, M. Zion & R. Lindsay. (2005) Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thrombosis Research 116:1, pages 1-13.
Crossref
Erik JJ Duschek, Simone J Neele, M Christella LGD Thomassen, Jan Rosing & Coen Netelenbos. (2004) Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men. Blood Coagulation & Fibrinolysis 15:8, pages 649-655.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.